Featured Story | Friday, June 19, 2020 After teaming up with GlaxoSmithKline and Dynavax early on in the pandemic, Chinese biotech Clover Biopharmaceuticals has started trials of its COVID-19 vaccine and expects data in August. read more |
| |
|---|
|
Top Stories Friday, June 19, 2020 Roche’s ipatasertib has improved progression-free survival in a subgroup of prostate cancer patients in a phase 3 trial. The drug failed to improve outcomes in the broader population, but, with overall survival data still maturing, Roche thinks the findings are encouraging for its chances of claiming a slice of a market targeted by AstraZeneca. read more Friday, June 19, 2020 Assembly Biosciences has been handed back the rights for a series of gastrointestinal microbiome assets from AbbVie as it filters out unwanted pacts from its Allergan subsidiary. read more Monday, June 15, 2020 Hit hard by COVID-19, five NYC biotech companies develop innovative diagnostic technologies that provide faster and better tests. read more Friday, June 19, 2020 Pandemic or no pandemic, biotech IPOs just keep on coming. Let’s add another two to the list: Forma Therapeutics, which pulled off a $278 million listing, and Repare Therapeutics, which bagged $220 million in its Wall Street debut. read more Monday, June 15, 2020 Sponsors are transforming and future-proofing their clinical research by incorporating virtual options in study protocols. Discover why patients are key to the success of these digital strategies. read more Friday, June 19, 2020 Finch Therapeutics’ lead microbiome drug beat the standard of care at banishing recurrent Clostridium difficile infections in a phase 2 study, laying the groundwork for a second pivotal trial and teeing up a second program in hepatitis B. read more Friday, June 19, 2020 San Diego-based biotech Engrail Therapeutics has raised $32 million as it looks to kickstart its first clinical work for its central nervous system med. read more Thursday, June 18, 2020 Regeneron launched human trials of its anti-COVID cocktail REGN-COV2 last week, and now its scientists are explaining how they chose the two antibodies that comprise the treatment. The key was to thwart the ability of the virus to mutate by selecting antibodies that bind differently to their target, they explained in a new study. read more Friday, June 19, 2020 AstraZeneca exec Dubovsky joins Novavax as CMO; Eli Lilly's Gandhi leaves for Dana-Farber; Fjällskog tapped as Sensei CMO. read more Friday, June 19, 2020 Two China-made inactivated COVID-19 vaccines by Sinopharm and Sinovac passed mid-phase clinical tests. Takeda got an FDA warning letter, and the Japanese pharma sold seven neuroscience candidates to Neurocrine Biosciences for up to $2 billion. And more. read more Enrollment Showcase | Sponsored by: University of Florida College of Pharmacy Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program. |
| |
|---|
|
Resources Sponsored by: Cenduit Download this case study to read how Cenduit helped one client successfully navigate mid-study changes to medication management. Sponsored by: Research Solutions Learn four ways to squeeze more value from your limited R&D resources. Sponsored by: BioAnalytix Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies Sponsored by: Catalent In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. Learn more. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Presented by: ICON Clinical Research Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Clarify Health Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Sponsored by: Outer Edge Technology Businesses must maintain pre-pandemic levels of productivity with smaller IT budgets. Learn why an effective Cloud Strategy is imperative for success in these unprecedented times. | 
